Research Projects & Grants

For Profit Organization

  • A phase III multicenter clinical trial of Analatro® [antivenin latrodectus (black widow) equine immune F(ab)2] in patients with systemic latrodectism, Role: PI, Instituto Bioclon S.A., (12/2013 - 12/2014) Status: Completed

Internal

  • Toxicology investigator's consortium (ToxIC) database., Role: Investigator, LLU Dept. of Emergency Medicine, (04/2025 - 04/2026) Status: Approved
  • Systemic Review of Patients with Coronavirus Disease 2019 (COVID-19) Treated at Loma Linda University Medical Center Emergency Department, Role: Investigator, LLU Dept. of Emergency Medicine, (04/2020) Status: Approved
  • Envenomation telemedicine, Role: Investigator, LLU Dept. of Emergency Medicine, (03/2015 - 03/2016) Status: Completed